Letter: Addressing Gaps in Hospital-Based Hepatitis C Screening—Insights and Recommendations

IF 6.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2025-01-16 DOI:10.1111/apt.18460
Zhen Deng, Lincheng Duan, Kai Wang
{"title":"Letter: Addressing Gaps in Hospital-Based Hepatitis C Screening—Insights and Recommendations","authors":"Zhen Deng,&nbsp;Lincheng Duan,&nbsp;Kai Wang","doi":"10.1111/apt.18460","DOIUrl":null,"url":null,"abstract":"<p>We have carefully reviewed Ferrarese et al.'s study on the effectiveness of hospital-based hepatitis C virus (HCV) screening activities [<span>1</span>]. This research offers crucial data for identifying HCV-infected patients beyond current national screening policies, and provides valuable insights for public health interventions. However, we propose several considerations and recommendations to enhance the study.</p><p>Firstly, the study does not sufficiently analyse patients' comorbid conditions. Hospitalised patients often have chronic diseases such as diabetes, metabolic syndrome or cardiovascular diseases, which increase HCV infection risk and influence treatment adherence and outcomes [<span>2, 3</span>]. Stratified analysis by comorbidities could clarify the interplay between HCV infection and overall health, aiding in the development of targeted screening and treatment strategies.</p><p>Secondly, the research inadequately addresses patients' socioeconomic status (SES), a key factor affecting healthcare access and screening participation [<span>4, 5</span>]. Individuals with low-income or education levels may encounter greater barriers due to financial constraints or lack of information [<span>6</span>]. Collecting data on income, education and employment, and examining their impact on screening and treatment, would provide a more comprehensive understanding of how socioeconomic disparities impede HCV prevention and control.</p><p>Thirdly, while the study notes that 82.5% of hospitalised patients were not screened, it does not examine the specific characteristics of this unscreened group, such as age, gender, comorbidities or departmental distribution. This selection bias may limit the representativeness of the findings. We recommend a retrospective analysis of hospital records to identify traits of the unscreened population, enabling a more accurate assessment of HCV prevalence among hospitalised patients and the creation of more inclusive screening strategies.</p><p>Additionally, the study finds that female patients with positive viral loads are significantly older than males, while it does not explore the reasons for this gender disparity. This difference might relate to unique risk factors for disease progression in women or barriers to healthcare access. Future research should investigate this phenomenon to optimise screening and treatment approaches for female patients.</p><p>Lastly, the study mentions that some patients were lost to follow-up after referral to local centres but does not suggest specific improvements for follow-up management. Loss to follow-up can severely impact treatment outcomes, particularly for foreign patients or those with limited medical resources. To address these issues comprehensively, we suggest integrating social work practices to enhance HCV screening and treatment effectiveness. Health education and outreach through community lectures and multilingual support can help high-risk groups understand the importance of screening and overcome cultural or language barriers. Providing financial assistance or mobile screening services for low-income or resource-limited populations can reduce participation barriers. For foreign and female patients, culturally adapted educational materials, flexible screening schedules and childcare services can offer targeted support. Additionally, case management models and digital follow-up tools can improve long-term adherence, while establishing patient support groups and advocating for policy enhancements (such as expanding free screening coverage) can create synergistic effects from grassroots to policy levels.</p><p>In conclusion, Ferrarese et al. have significantly advanced HCV screening efforts. Addressing the aforementioned issues would enhance the study's credibility and practical applicability, providing more comprehensive scientific support for optimising screening and treatment strategies.</p><p><b>Zhen Deng:</b> methodology, formal analysis, writing – original draft. <b>Lincheng Duan:</b> methodology, writing – original draft. <b>Kai Wang:</b> conceptualization, methodology, supervision, writing – review and editing.</p><p>The authors declare no conflicts of interest.</p><p>This article is linked to Ferrarese et al papers. To view these articles, visit https://doi.org/10.1111/apt.18433 and https://doi.org/10.1111/apt.18505.</p>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"61 5","pages":"915-916"},"PeriodicalIF":6.6000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18460","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.18460","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We have carefully reviewed Ferrarese et al.'s study on the effectiveness of hospital-based hepatitis C virus (HCV) screening activities [1]. This research offers crucial data for identifying HCV-infected patients beyond current national screening policies, and provides valuable insights for public health interventions. However, we propose several considerations and recommendations to enhance the study.

Firstly, the study does not sufficiently analyse patients' comorbid conditions. Hospitalised patients often have chronic diseases such as diabetes, metabolic syndrome or cardiovascular diseases, which increase HCV infection risk and influence treatment adherence and outcomes [2, 3]. Stratified analysis by comorbidities could clarify the interplay between HCV infection and overall health, aiding in the development of targeted screening and treatment strategies.

Secondly, the research inadequately addresses patients' socioeconomic status (SES), a key factor affecting healthcare access and screening participation [4, 5]. Individuals with low-income or education levels may encounter greater barriers due to financial constraints or lack of information [6]. Collecting data on income, education and employment, and examining their impact on screening and treatment, would provide a more comprehensive understanding of how socioeconomic disparities impede HCV prevention and control.

Thirdly, while the study notes that 82.5% of hospitalised patients were not screened, it does not examine the specific characteristics of this unscreened group, such as age, gender, comorbidities or departmental distribution. This selection bias may limit the representativeness of the findings. We recommend a retrospective analysis of hospital records to identify traits of the unscreened population, enabling a more accurate assessment of HCV prevalence among hospitalised patients and the creation of more inclusive screening strategies.

Additionally, the study finds that female patients with positive viral loads are significantly older than males, while it does not explore the reasons for this gender disparity. This difference might relate to unique risk factors for disease progression in women or barriers to healthcare access. Future research should investigate this phenomenon to optimise screening and treatment approaches for female patients.

Lastly, the study mentions that some patients were lost to follow-up after referral to local centres but does not suggest specific improvements for follow-up management. Loss to follow-up can severely impact treatment outcomes, particularly for foreign patients or those with limited medical resources. To address these issues comprehensively, we suggest integrating social work practices to enhance HCV screening and treatment effectiveness. Health education and outreach through community lectures and multilingual support can help high-risk groups understand the importance of screening and overcome cultural or language barriers. Providing financial assistance or mobile screening services for low-income or resource-limited populations can reduce participation barriers. For foreign and female patients, culturally adapted educational materials, flexible screening schedules and childcare services can offer targeted support. Additionally, case management models and digital follow-up tools can improve long-term adherence, while establishing patient support groups and advocating for policy enhancements (such as expanding free screening coverage) can create synergistic effects from grassroots to policy levels.

In conclusion, Ferrarese et al. have significantly advanced HCV screening efforts. Addressing the aforementioned issues would enhance the study's credibility and practical applicability, providing more comprehensive scientific support for optimising screening and treatment strategies.

Zhen Deng: methodology, formal analysis, writing – original draft. Lincheng Duan: methodology, writing – original draft. Kai Wang: conceptualization, methodology, supervision, writing – review and editing.

The authors declare no conflicts of interest.

This article is linked to Ferrarese et al papers. To view these articles, visit https://doi.org/10.1111/apt.18433 and https://doi.org/10.1111/apt.18505.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
信函:解决以医院为基础的丙型肝炎筛查的差距——见解和建议
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
期刊最新文献
Issue Information Effects of a 12-Week Mediterranean-Type Time-Restricted Feeding Protocol in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Controlled Trial—The ‘CHRONO-NAFLD Project’ Letter: Iron Metabolism in SLD—A Complex Puzzle That Requires Further Evaluation Editorial: Beyond Clinical Trials—Real-World Data Suggest Usefulness of GLP-1 RAs in MASLD Treatment. Authors' Reply Editorial: Beyond Clinical Trials—Real-World Data Suggest Usefulness of GLP-1 RAs in MASLD Treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1